about
Management of hair loss associated with endocrine therapy in patients with breast cancer: an overviewClinical utilities of aromatase inhibitors in breast cancerEffects of the traditional Chinese medicine Yi Shen Jian Gu granules on aromatase inhibitor-associated musculoskeletal symptoms: a study protocol for a multicenter, randomized, controlled clinical trial.Pain in cancer survivorsEstrogen receptors involvement in intervertebral discogenic pain of the elderly women: colocalization and correlation with the expression of Substance P in nucleus pulposus.Patient-reported symptoms and discontinuation of adjuvant aromatase inhibitor therapy.Women commencing anastrozole, letrozole or tamoxifen for early breast cancer: the impact of comorbidity and demographics on initial choice.Prevalence of aromatase inhibitor-induced arthralgia in breast cancer: a systematic review and meta-analysis.Weight Gain After Breast Cancer Diagnosis and All-Cause Mortality: Systematic Review and Meta-Analysis.Antihormonal treatment associated musculoskeletal pain in women with breast cancer in the adjuvant settingRandomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS).Aromatase inhibitors induced autoimmune disorders in patients with breast cancer: A review.Acupuncture for joint symptoms related to aromatase inhibitor therapy in postmenopausal women with early-stage breast cancer: a narrative review.Obesity and breast cancer: not only a risk factor of the disease.Cancer rehabilitation and palliative care: critical components in the delivery of high-quality oncology services.A prospective study of aromatase inhibitor therapy initiation and self-reported side effects.Molecular basis of aromatase inhibitor associated arthralgia: known and potential candidate genes and associated biomarkers.Relations between arthralgia and fear of recurrence: results of a cross-sectional study of breast cancer patients treated with adjuvant aromatase inhibitors therapy.Self-efficacy for coping with symptoms moderates the relationship between physical symptoms and well-being in breast cancer survivors taking adjuvant endocrine therapy.Aromatase inhibitor associated arthralgia: the importance of oncology provider-patient communication about side effects and potential management through physical activity.Effects of a multicomponent physical activity behavior change intervention on breast cancer survivor health status outcomes in a randomized controlled trial.Influence of aromatase inhibitors therapy on the occurrence of rheumatoid arthritis in women with breast cancer: results from a large population-based study of the Italian Society for Rheumatology.Opioid use among female breast cancer patients using different adjuvant endocrine therapy regimens.Genomic risk prediction of aromatase inhibitor-related arthralgia in patients with breast cancer using a novel machine-learning algorithm.Quality of life and impact of pain in women treated with aromatase inhibitors for breast cancer. A multicenter cohort study.Patient-reported factors associated with adherence to adjuvant endocrine therapy after breast cancer: an integrative review.Ageing perceptions and non-adherence to aromatase inhibitors among breast cancer survivors.Grip Strength in Women Being Treated for Breast Cancer and Receiving Adjuvant Endocrine Therapy: Systematic Review.Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial.Factors associated with knee pain in 5148 women aged 50 years and older: A population-based study.A systematic review of the risk factors for clinical response to opioids for all-age patients with cancer-related pain and presentation of the paediatric STOP pain study.Aromatase inhibitors and anti-synthetase syndrome.Effect of neuromuscular taping on musculoskeletal disorders secondary to the use of aromatase inhibitors in breast cancer survivors: a pragmatic randomised clinical trial.Endocrine therapy for breast cancer in the primary care settingOsteoporosis and musculoskeletal complications related to therapy of breast cancerPharmacokinetic evaluation of a transdermal anastrozole-in-adhesive formulation
P2860
Q26744259-369EC903-362B-4189-9760-225F3603C8C0Q28081168-F91779B6-F4E3-414C-B19C-D9E3B06ED96EQ33647466-F446E63E-64F5-419E-9E2B-4838A221D07EQ33650576-EB1C9C24-606E-469B-A812-FE36DB824330Q33888709-6AFB91F0-618B-496F-8323-62F9C58670A2Q34020925-E7816631-805C-4714-899A-9F61C9E7D724Q35083481-62807107-7055-4093-802B-1E6518E370BBQ36282120-741EDF16-7058-40ED-BFA9-1F9C99D4A24BQ36468884-2B8FA4F6-E61B-4CDE-92A8-7D3170961DADQ37174823-CEA73583-EB08-425C-AB3C-68B62B324E40Q37603181-BF30D1B9-EC79-486E-8C8B-223FAB158852Q37669293-256A9461-BB38-487A-A6AC-9CD3C9BE5E78Q38367083-31A95B95-58E3-454F-BA4F-1FF2CE538D13Q38436984-0BC54556-8CF8-4D0C-AEE7-89D451FB948DQ38575246-D7375C09-71BF-48EF-A7C7-7A52B00C5129Q38877166-3DC3FA5A-07BA-47D5-9A0A-3C217D264C74Q38956073-C9FE6846-C51F-44A2-A623-479CE401F4BBQ39190544-C1E87362-6585-4224-85F4-2C37197AB91CQ39193674-0A5FDD1C-8CEE-462A-A518-95601E1600FEQ40117148-C44A040B-1A4A-4E4B-813C-7B6DAE051B05Q41036355-9B17420B-7A26-4F88-A919-A8A8A59FE4C6Q42699228-53070ABC-A74B-4911-BA06-09B9E9A84941Q44346721-81A03F9C-D0C5-4886-959C-C14CCE8D5F94Q45943654-23ADF935-BE9C-4B41-8E55-B27B0687BDE9Q47201467-3749CEF3-737C-49C2-9F11-DC72524B45B5Q47624971-330F0BF8-D876-451E-A15E-A946C720FE02Q47656859-1DFB416E-97F7-4E31-A444-BD77E2C05BABQ47882185-0EEB949A-81DE-49CD-BD77-EFDB9B6F8B9FQ51072176-D77C661C-FDCA-44E6-861A-97B59A00135FQ53080073-97C1A133-6F13-46F6-B2C5-B95E11D05D14Q54943506-2AC71461-14AF-4B86-8528-4138F5213E29Q55215138-89BFEF84-84F5-4E20-8857-4FF555C91E1CQ55423368-06D96AD2-7A69-4906-AFEA-51F325A2A33BQ57108564-930FA7ED-4D32-4183-938B-A91D2CE02FBBQ57108686-E69AA21D-ADE9-43C2-B06C-A251DA68EC36Q59125883-E547B29C-7B49-4A3E-BFFB-10D61B39C1AB
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Aromatase inhibitor-induced arthralgia: a review.
@en
type
label
Aromatase inhibitor-induced arthralgia: a review.
@en
prefLabel
Aromatase inhibitor-induced arthralgia: a review.
@en
P2860
P356
P1433
P1476
Aromatase inhibitor-induced arthralgia: a review.
@en
P2093
P Niravath
P2860
P304
P356
10.1093/ANNONC/MDT037
P577
2013-03-06T00:00:00Z